vs
Apellis Pharmaceuticals, Inc.（APLS）与MONRO, INC.（MNRO）财务数据对比。点击上方公司名可切换其他公司
MONRO, INC.的季度营收约是Apellis Pharmaceuticals, Inc.的1.5倍（$293.4M vs $199.9M），MONRO, INC.净利率更高（3.8% vs -29.5%，领先33.3%），MONRO, INC.同比增速更快（-4.0% vs -5.9%），MONRO, INC.自由现金流更多（$9.1M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -2.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
蒙罗公司（Monro, Inc.）是一家汽车服务企业，创始并总部设在美国纽约州罗切斯特。截至2025年，蒙罗共拥有1260家门店，按门店数量与营收计算，是北美仅次于Driven Brands的第二大汽车服务企业。
APLS vs MNRO — 直观对比
营收规模更大
MNRO
是对方的1.5倍
$199.9M
营收增速更快
MNRO
高出1.9%
-5.9%
净利率更高
MNRO
高出33.3%
-29.5%
自由现金流更多
MNRO
多$23.4M
$-14.3M
两年增速更快
APLS
近两年复合增速
-2.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $293.4M |
| 净利润 | $-59.0M | $11.1M |
| 毛利率 | — | 34.9% |
| 营业利润率 | -25.6% | 6.3% |
| 净利率 | -29.5% | 3.8% |
| 营收同比 | -5.9% | -4.0% |
| 净利润同比 | -62.2% | 143.1% |
| 每股收益（稀释后） | $-0.40 | $0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSMNRO
| Q4 25 | $199.9M | $293.4M | ||
| Q3 25 | $458.6M | $288.9M | ||
| Q2 25 | $178.5M | $301.0M | ||
| Q1 25 | $166.8M | $295.0M | ||
| Q4 24 | $212.5M | $305.8M | ||
| Q3 24 | $196.8M | $301.4M | ||
| Q2 24 | $199.7M | $293.2M | ||
| Q1 24 | $172.3M | $310.1M |
净利润APLSMNRO
| Q4 25 | $-59.0M | $11.1M | ||
| Q3 25 | $215.7M | $5.7M | ||
| Q2 25 | $-42.2M | $-8.1M | ||
| Q1 25 | $-92.2M | $-21.3M | ||
| Q4 24 | $-36.4M | $4.6M | ||
| Q3 24 | $-57.4M | $5.6M | ||
| Q2 24 | $-37.7M | $5.9M | ||
| Q1 24 | $-66.4M | $3.7M |
毛利率APLSMNRO
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 35.7% | ||
| Q2 25 | — | 35.5% | ||
| Q1 25 | — | 33.0% | ||
| Q4 24 | — | 34.3% | ||
| Q3 24 | — | 35.3% | ||
| Q2 24 | — | 37.2% | ||
| Q1 24 | — | 35.5% |
营业利润率APLSMNRO
| Q4 25 | -25.6% | 6.3% | ||
| Q3 25 | 48.7% | 4.4% | ||
| Q2 25 | -18.6% | -2.0% | ||
| Q1 25 | -50.0% | -8.1% | ||
| Q4 24 | -12.3% | 3.3% | ||
| Q3 24 | -24.0% | 4.4% | ||
| Q2 24 | -14.7% | 4.5% | ||
| Q1 24 | -36.0% | 3.3% |
净利率APLSMNRO
| Q4 25 | -29.5% | 3.8% | ||
| Q3 25 | 47.0% | 2.0% | ||
| Q2 25 | -23.6% | -2.7% | ||
| Q1 25 | -55.3% | -7.2% | ||
| Q4 24 | -17.1% | 1.5% | ||
| Q3 24 | -29.2% | 1.9% | ||
| Q2 24 | -18.9% | 2.0% | ||
| Q1 24 | -38.5% | 1.2% |
每股收益（稀释后）APLSMNRO
| Q4 25 | $-0.40 | $0.35 | ||
| Q3 25 | $1.67 | $0.18 | ||
| Q2 25 | $-0.33 | $-0.28 | ||
| Q1 25 | $-0.74 | $-0.74 | ||
| Q4 24 | $-0.30 | $0.15 | ||
| Q3 24 | $-0.46 | $0.18 | ||
| Q2 24 | $-0.30 | $0.19 | ||
| Q1 24 | $-0.54 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $4.9M |
| 总债务越低越好 | — | $45.0M |
| 股东权益账面价值 | $370.1M | $604.9M |
| 总资产 | $1.1B | $1.6B |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资APLSMNRO
| Q4 25 | $466.2M | $4.9M | ||
| Q3 25 | $479.2M | $10.5M | ||
| Q2 25 | $370.0M | $7.8M | ||
| Q1 25 | $358.4M | $20.8M | ||
| Q4 24 | $411.3M | $10.2M | ||
| Q3 24 | $396.9M | $20.9M | ||
| Q2 24 | $360.1M | $18.7M | ||
| Q1 24 | $325.9M | $6.6M |
总债务APLSMNRO
| Q4 25 | — | $45.0M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $71.5M | ||
| Q1 25 | — | $61.3M | ||
| Q4 24 | — | $59.3M | ||
| Q3 24 | — | $62.0M | ||
| Q2 24 | — | $112.0M | ||
| Q1 24 | $93.1M | $102.0M |
股东权益APLSMNRO
| Q4 25 | $370.1M | $604.9M | ||
| Q3 25 | $401.2M | $601.7M | ||
| Q2 25 | $156.3M | $604.9M | ||
| Q1 25 | $164.2M | $620.8M | ||
| Q4 24 | $228.5M | $648.9M | ||
| Q3 24 | $237.1M | $651.9M | ||
| Q2 24 | $264.3M | $654.4M | ||
| Q1 24 | $266.7M | $656.8M |
总资产APLSMNRO
| Q4 25 | $1.1B | $1.6B | ||
| Q3 25 | $1.1B | $1.6B | ||
| Q2 25 | $821.4M | $1.6B | ||
| Q1 25 | $807.3M | $1.6B | ||
| Q4 24 | $885.1M | $1.7B | ||
| Q3 24 | $901.9M | $1.7B | ||
| Q2 24 | $904.5M | $1.7B | ||
| Q1 24 | $831.9M | $1.7B |
负债/权益比APLSMNRO
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.10× | ||
| Q4 24 | — | 0.09× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | 0.35× | 0.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $17.8M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $9.1M |
| 自由现金流率自由现金流/营收 | -7.1% | 3.1% |
| 资本支出强度资本支出/营收 | 0.1% | 3.0% |
| 现金转化率经营现金流/净利润 | — | 1.60× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $49.6M |
8季度趋势，按日历期对齐
经营现金流APLSMNRO
| Q4 25 | $-14.2M | $17.8M | ||
| Q3 25 | $108.5M | $32.3M | ||
| Q2 25 | $4.4M | $-1.9M | ||
| Q1 25 | $-53.4M | $28.9M | ||
| Q4 24 | $19.4M | $14.8M | ||
| Q3 24 | $34.1M | $62.6M | ||
| Q2 24 | $-8.3M | $25.6M | ||
| Q1 24 | $-133.0M | $-5.3M |
自由现金流APLSMNRO
| Q4 25 | $-14.3M | $9.1M | ||
| Q3 25 | $108.3M | $26.6M | ||
| Q2 25 | $4.4M | $-9.3M | ||
| Q1 25 | $-53.4M | $23.2M | ||
| Q4 24 | $19.3M | $7.9M | ||
| Q3 24 | — | $57.6M | ||
| Q2 24 | $-8.4M | $16.8M | ||
| Q1 24 | $-133.3M | $-11.9M |
自由现金流率APLSMNRO
| Q4 25 | -7.1% | 3.1% | ||
| Q3 25 | 23.6% | 9.2% | ||
| Q2 25 | 2.5% | -3.1% | ||
| Q1 25 | -32.0% | 7.9% | ||
| Q4 24 | 9.1% | 2.6% | ||
| Q3 24 | — | 19.1% | ||
| Q2 24 | -4.2% | 5.7% | ||
| Q1 24 | -77.3% | -3.8% |
资本支出强度APLSMNRO
| Q4 25 | 0.1% | 3.0% | ||
| Q3 25 | 0.0% | 2.0% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.0% | 1.9% | ||
| Q4 24 | 0.0% | 2.2% | ||
| Q3 24 | 0.0% | 1.6% | ||
| Q2 24 | 0.0% | 3.0% | ||
| Q1 24 | 0.2% | 2.1% |
现金转化率APLSMNRO
| Q4 25 | — | 1.60× | ||
| Q3 25 | 0.50× | 5.71× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.23× | ||
| Q3 24 | — | 11.08× | ||
| Q2 24 | — | 4.37× | ||
| Q1 24 | — | -1.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
MNRO
| Tires | $150.2M | 51% |
| Maintenance | $73.5M | 25% |
| Brakes | $35.1M | 12% |
| Steering | $24.9M | 8% |
| Batteries | $6.2M | 2% |
| Exhaust | $3.2M | 1% |
